Estradiol topical - Medicis

Drug Profile

Estradiol topical - Medicis

Alternative Names: Estrasorb

Latest Information Update: 01 Mar 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Novavax
  • Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Vasomotor symptoms

Most Recent Events

  • 20 Aug 2013 Biomarkers information updated
  • 11 Dec 2012 Medicis Pharmaceutical Corporation has been acquired by Valeant Pharmaceuticals International
  • 11 Dec 2012 Valeant Pharmaceuticals acquires Medicis Pharmaceutical Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top